LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Lexeo Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.76+0.12 (+4.55%)
Close on Oct 19, 2026
- Market cap
- $236.33M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Lexeo Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 29, 2026 | Sep 29, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2026 | Sep 22, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2026 | Jun 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2025 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 28, 2026 | Apr 30, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Feb 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2025 | Nov 5, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 16, 2025 | Oct 17, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 7, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | May 27, 2025 | May 27, 2025 | SEC EDGAR |
| Quarterly report, amended | 10-Q/A | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 7, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 24, 2025 | Mar 24, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2024 | Dec 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 11, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2024 | Oct 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2024 | Aug 12, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2024 | Jul 15, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 8, 2024 | Jul 8, 2024 | SEC EDGAR |